Research programme: halimide analogues - Nereus
Alternative Names: NPI 2350; NPI 2362; NPI 2386; NPI 2460Latest Information Update: 16 Oct 2007
At a glance
- Originator Kyoto University; University of California
- Developer Nereus Pharmaceuticals
- Class Small molecules
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer